Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Fri, 06.11.2026       Nynomic AG

Company Name: Nynomic AG ISIN: DE000A0MSN11   Reason for the research: Update Recommendation: BUY Target price: EUR 30 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr Q3 prelims: OI at multi-year high; top end of guidance in reachTopic: Nynomic released preliminary 9M figures, showing accelerat [ … ]
Fri, 06.11.2026       Deutsche Beteiligungs AG

Company Name: Deutsche Beteiligungs AG ISIN: DE000A1TNUT7   Reason for the research: Update Recommendation: BUY Target price: EUR 36 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr Q3 out: Multiples turn, exits keep comingQ3 NAV per share came in at € 33.84, up 0.6% qoq (Q2: € 33.65;  [ … ]
Fri, 06.11.2026       bet-at-home.com AG

Company Name: bet-at-home.com AG ISIN: DE000A0DNAY5   Reason for the research: Update Recommendation: BUY Target price: EUR 4.7 Target price on sight of: 12 months Last rating change: Analyst: Sarah Hellemann Q3'26: Setting the stage for a stronger performance from FY27e Yesterday, bet-at-home.com reported Q3 figures: Online Gami [ … ]
Fri, 06.11.2026       Westwing Group SE

Company Name: Westwing Group SE ISIN: DE000A2N4H07   Reason for the research: Update Recommendation: BUY Target price: EUR 23.50 Target price on sight of: 12 months Last rating change: Analyst: Christian Sandherr Q3 release further underpins the investment caseTopic: Westwing delivered its fifth consecutive quarter of growth, des [ … ]
Fri, 06.11.2026       https://research-hub.de/companies/hellofresh-se

HelloFresh’s (HF) Q3 broadly matched its September warning, with revenue down 11.3% cc and orders down 17.9%, partly offset by 7.5% AOV growth. Marketing spend fell 24%, including a 33% cut in RTE, as weaker-than-planned contribution economics led management to protect unit economics instead of scaling acquisition. Group contribution margin fell 1.3pp to 23.3%. HF expects in Q4 to fix margins, as management expects procurement and cooking costs to normalize. The growth test shifts to 2027, when higher marketing must prove it can restore customer acquisition and stabilize orders at attractive returns. PT EUR 1.80, SELL unchanged. The full update can be downloaded under https://research-hub.de/companies/hellofresh-se
Fri, 06.11.2026       https://research-hub.de/companies/the-platform-group-se-co-kgaa

The Platform Group (TPG) reported 9M 26 revenue growth of 17% and adjusted EBITDA growth of 16%, although Q3 margins weakened considerably. Management confirmed FY26 guidance but achieving its EUR 1.0bn revenue target would require an ambitious increase in Q4. Deleveraging progressed, with net debt declining to EUR 108m and leverage reaching 1.7x. However, AEP financing remains unresolved, while subsidiarylevel concerns persist. Despite encouraging operational developments, the absence of comprehensive financial statements prevents a reliable assessment of earnings quality, liquidity, and financial stability. With only minor changes to our estimates, we also incorporate less debt and a higher number of shares. We maintain our rating and price target Under Review pending greater financial transparency. The full update can be downloaded under https://research-hub.de/companies/the-platform-group-se-co-kgaa
Fri, 06.11.2026       https://research-hub.de/companies/suss-microtec-se

The Q3 call gave us a clearer picture of SUSS’s FY27 sales potential, with EUR 415-435m of the backlog already scheduled for delivery next year and management expecting the production ramp to start in Q1. With theoretical capacity of up to EUR 1.1bn, SUSS has room to exceed our EUR 673m sales forecast, provided suppliers can keep up. The less exciting part is gross margins, where the benefits from new products and the Garching relocation will take longer to show up. We have therefore trimmed our FY27/28 gross margin assumptions slightly, but still see an attractive risk/reward at 8x FY27E EV/EBIT. We maintain our EUR 99.00 price target and BUY rating. The full update can be downloaded under https://research-hub.de/companies/suss-microtec-se
Fri, 06.11.2026       https://research-hub.de/companies/lanxess-ag

LANXESS delivered a decent Q3, with pricing and cost savings supporting earnings and cash flow improving noticeably, although the underlying picture is less convincing. Volumes remain sluggish, and US tariff refunds provided a meaningful boost to EBITDA. The revised FY26 guidance looks achievable, but rising energy costs and weak industrial demand leave limited room for upside near term. We still like the setup into 2027, with depressed utilization and a lower cost base offering considerable earnings potential if demand picks up. Deleveraging will take time, but with much of the bad news already reflected in the valuation, we see a reasonable margin for error. We reiterate BUY with a EUR 20.00 price target. LANXESS will be participating in our “Chemicals & Beyond” conference on 8 December: Please register under: https://research-hub.de/events/registration/2026-12-08-10-30/LXS-GR The full update can be downloaded under https://research-hub.de/companies/lanxess-ag
Fri, 06.11.2026       https://research-hub.de/companies/krones-ag

Krones’ Q3 results confirm the picture outlined in October’s guidance reset: subdued revenue growth alongside resilient underlying profitability. Revenue increased by 0.3% yoy to EUR 1.38bn, while reported EBITDA rose by 12.7% to EUR 160m. However, tariff refunds supported earnings, with the company reporting an adjusted Q3 EBITDA margin of 10.7%, versus 11.6% reported. Stable order intake and a substantial backlog provide support, although conversion into revenue remains a key constraint. The revised FY26 outlook was reiterated. We maintain our BUY recommendation and EUR 140.00 price target. The full update can be downloaded under https://research-hub.de/companies/krones-ag
Thu, 05.11.2026       https://research-hub.de/companies/nordex-se

Nordex delivered Q3 results in line with preliminary figures, with EBITDA more than doubling yoy to EUR 278m and the margin reaching 12.7%. Strong order momentum across Projects and Service lifted the combined order book by 30% yoy to EUR 19.3bn, providing solid revenue visibility. Following its preliminary results, management raised FY26 EBITDA margin guidance to 11.5–12.5%, already reaching the upper end of its mid-term target range. While strong demand across key markets supports further growth, the industry's high cyclicality remains a key concern. Despite this, based on our DCF valuation, we maintain our BUY rating and EUR 47.00 PT but implying only 15% upside given our cautious stance on the duration of the current cycle. The full update can be downloaded under https://research-hub.de/companies/nordex-se

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

© 2026 Select Sector SPDRs

* * *

More Sector related Investment Ideas
© 2026 WEBs Investments ETFs
Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 22.11.2026, Calendar Week 47, 326th day of the year, 39 days remaining until EoY.